Ind-Swift Laboratories Share Price
360.30-12.40 (-3.33%)
+251.27% past 1 Year
Headquartered in Chandigarh, India, Ind-Swift Laboratories Ltd is a public limited company incorporated on January 04, 1995 under the provision of companies Act, 2013. The company is global manufacturer of
Corporate filings & documents
Announcements
Please find enclosed outcome of Board Meeting held on September 02 2026.
1 day agoPlease find enclosed outcome of Board Meeting held on September 02 2026.
1 day agoPlease refer attached pdf regarding clarification sought from company regarding movement in value .
1 week agoPlease refer attached pdf regarding clarification sought from company regarding movement in value .
1 week agoThe Exchange has sought clarification from Ind-Swift Laboratories Ltd on August 27 2026 with reference to Movement in Volume.<BR><BR>The reply is awaited.
1 week agoThe Exchange has sought clarification from Ind-Swift Laboratories Ltd on August 27 2026 with reference to Movement in Volume.<BR><BR>The reply is awaited.
1 week agoPlease find enclosed Transcript of Earning Call held on August 17 2026.
2 weeks agoPlease find enclosed Transcript of Earning Call held on August 17 2026.
2 weeks agoPlease find enclosed press release titled as Ind-Swift to make Jammu facility EUGMP and PICS Compliant targets additional revenue of 100 crores from 2029-30 onwards .
2 weeks agoPlease find enclosed press release titled as Ind-Swift to make Jammu facility EUGMP and PICS Compliant targets additional revenue of 100 crores from 2029-30 onwards .
2 weeks agoAudio recording of earning conference call held on 17.08.2026 on un-audited financial results for the quarter ended 30.06.2026.
2 weeks agoAudio recording of earning conference call held on 17.08.2026 on un-audited financial results for the quarter ended 30.06.2026.
2 weeks agoPlease find attached intimation regarding the investor presentation on un-audited financial results for the quarter ended June 30 2026.
2 weeks agoPlease find attached intimation regarding the investor presentation on un-audited financial results for the quarter ended June 30 2026.
2 weeks agoPlease find enclosed Schedule of Analyst / Investor Meet will be held on Monday 17th August 2026 at 03.00 P.M. IST in respect of financial results of the Company for the quarter ended 30th June 2026.
3 weeks agoPlease find enclosed Schedule of Analyst / Investor Meet will be held on Monday 17th August 2026 at 03.00 P.M. IST in respect of financial results of the Company for the quarter ended 30th June 2026.
3 weeks agoPlease find enclosed report of the Monitoring Agency for the quarter ended June 30 2026.
3 weeks agoPlease find enclosed report of the Monitoring Agency for the quarter ended June 30 2026.
3 weeks agoPlease refer attached pdf .
3 weeks agoPlease refer attached pdf .
3 weeks agoplease refer attached pdf.
3 weeks agoplease refer attached pdf.
3 weeks agoPlease find enclosed Statement of NIL Deviation for the Quarter ended June 30 2026
3 weeks agoPlease find enclosed Statement of NIL Deviation for the Quarter ended June 30 2026
3 weeks agoPlease find enclosed outcome of the Board Meeting Dated August 10 2026
3 weeks agoPlease find enclosed outcome of the Board Meeting Dated August 10 2026
3 weeks agoPlease refer attached pdf
3 weeks agoPlease refer attached pdf
3 weeks agoPlease find enclosed voting results along with scrutinizers report
3 weeks agoPlease find enclosed voting results along with scrutinizers report
3 weeks agoPlease find attached proceedings of EGM which was held today i.e. on 5th August 2026
4 weeks agoPlease find attached proceedings of EGM which was held today i.e. on 5th August 2026
4 weeks agoPlease refer attached pdf.
1 month agoPlease refer attached pdf.
1 month agoInd-Swift Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve Un-Audited Financial Results for the quarter ended June 30 2026.
1 month agoInd-Swift Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve Un-Audited Financial Results for the quarter ended June 30 2026.
1 month agoPlease refer attached pdf.
1 month agoPlease refer attached pdf.
1 month agoPlease refer attached pdf.
1 month agoPlease refer attached pdf.
1 month agoPlease refer attached pdf.
1 month agoPlease refer attached pdf.
1 month agoNewspaper Publication regarding dispatch of Notice calling Extra Ordinary General Meeting schedule to be held on 5th August 2026.
1 month agoNewspaper Publication regarding dispatch of Notice calling Extra Ordinary General Meeting schedule to be held on 5th August 2026.
1 month agoPlease refer attached pdf.
1 month agoPlease refer attached pdf.
1 month agoPlease refer attached pdf.
1 month agoPlease refer attached pdf.
1 month agoPlease refer attached pdf
1 month agoPlease refer attached pdf
1 month agoAnnual reports
Concalls & investor presentations
Aug 2026
ConcallPresentation
Aug 2026
ConcallPresentation
Jan 2026
ConcallPresentation
Nov 2025
ConcallPresentation
Nov 2020
ConcallPresentation
Corporate Actions
Date
Type
Details
2011-09-20
Dividend
1.0
2010-09-16
Dividend
1.0
Company details
Registered office
S C O 850 Shivalik Enclave, N A C Manimajra Chandigarh Union Territory PIN: 160101 Tel No: 0172 2730503 / 2730920 / 5061850 / 5061853 Fax No: 0172 2730504 / 2738294 Email: [email protected] Internet: www.indswiftlabs.com
Registrars
Alankit House , 4 E/2, Jhandewala Extension,New Delhi Alankit House , 4 E/2 Jhandewala Extension NULL PIN: Tel No: 91-11-4254 1234 Fax No: 91-11- 4154 3474 Email: [email protected] Internet: www.alankit.com
Management
Pardeep Verma, VP-Corp. Affairs, Company Secretary & Compliance Officer
Navrattan Munjal, Chairman & Managing Director
Navrattan Munjal, Chairman & Managing Director
Himanshu jain, Joint Managing Director
Rishav Mehta, Whole Time Director
Sahil Munjal, Whole Time Director
Neerja Chathley, Non Executive Independent Woman Director
Rajinder Kumar Gupta, Non Executive Independent Director
Subodh Gupta, Non Executive Independent Director
Details
BSE 532305
NSE INDSWFTLAB
ISIN INE915B01019